Peptide API
-
NMN
Ọmụmụ ihe ọmụmụ na mbụ na nke mmadụ na-atụ aro NMN nwere ike ịkwalite ogologo ndụ, ntachi obi anụ ahụ, na ịrụ ọrụ ọgụgụ isi.
Njirimara API:
Ịdị ọcha dị elu ≥99%
Pharmaceutical-ọkwa, adabara maka ọnụ ma ọ bụ injectable formulations
Emepụtara n'okpuru ụkpụrụ GMP
NMN API dị mma maka ojiji na mgbakwunye mgbochi ịka nká, usoro ọgwụgwọ metabolic, na nyocha ogologo ndụ.
-
Glucagon
Glucagon bụ homonụ peptide sitere n'okike ejiri dị ka ọgwụgwọ mberede maka nnukwu hypoglycemia ma mụọ maka ọrụ ya na nhazi usoro metabolic, mbelata ibu, na nchọpụta mgbari nri.
-
Motixafortide
Motixafortide bụ peptide synthetic CXCR4 antagonist emepụtara iji chịkọta mkpụrụ ndụ hematopoietic stem cell (HSCs) maka transplantation autologous na a na-amụkwa ya na oncology na immunotherapy.
-
Glepaglutide
Glepaglutide bụ analog GLP-2 na-eme ogologo oge nke emepụtara maka ọgwụgwọ nke ọrịa bowel mkpụmkpụ (SBS). Ọ na-eme ka nnabata nke eriri afọ na uto, na-enyere ndị ọrịa aka belata ịdabere na nri parenteral.
-
Elamipretide
Elamipretide bụ tetrapeptide ezubere iche nke mitochondria emepụtara iji gwọọ ọrịa sitere na arụrụ arụ mitochondrial kpatara, gụnyere isi mitochondrial myopathy, ọrịa Barth, na nkụda obi.
-
Pegcetacoplan
Pegcetacoplan bụ peptide cyclic pegylated nke na-arụ ọrụ dị ka onye na-egbochi mmechi mmeju C3 ezubere iche, nke emepụtara maka ọgwụgwọ ọrịa ndị na-akwado nkwado dị ka paroxysmal nocturnal hemoglobinuria (PNH) na atrophy geographic (GA) na mmebi macular metụtara afọ.
-
Palopegteriparatide
Palopegteriparatide bụ parathyroid hormone receptor agonist (PTH1R agonist), nke emepụtara maka ọgwụgwọ hypoparathyroidism na-adịghị ala ala. Ọ bụ analọgụ pegylated nke PTH (1-34) emebere iji nye ụkpụrụ calcium na-adịgide adịgide site na iji usoro ọgwụgwọ otu ugboro kwa izu.
-
GHRP-6
GHRP-6 (Homone uto na-ewepụta Peptide-6) bụ hexapeptide sịntetik nke na-arụ ọrụ dị ka secretagogue homonụ uto, na-akpali mwepụta anụ ahụ nke homonụ uto (GH) site na ịgbalite onye nnabata GHSR-1a.
Njirimara API:
Ịdị ọcha ≥99%
Emepụtara ya site na njikọ peptide siri ike (SPPS)
Enyere ya maka R&D na iji azụmaahịa
GHRP-6 bụ peptide nyocha dị iche iche maka nkwado metabolic, mmụgharị akwara, na mgbanwe homonụ.
-
GHRP-2
GHRP-2 (Homone uto na-ewepụta Peptide-2) bụ hexapeptide sịntetị na ike nke uto homonụ secretagogue, emebere iji kpalite ntọhapụ eke nke hormone uto (GH) site na ịgbalite onye nnabata GHSR-1a na hypothalamus na pituitary.
Njirimara API:
Ịdị ọcha ≥99%
Dị maka R&D na nnyefe azụmahịa, yana akwụkwọ QC zuru ezu
GHRP-2 bụ peptide nyocha bara uru na ngalaba nke endocrinology, ọgwụ na-emegharị ahụ, na ọgwụgwọ metụtara afọ.
-
Hexarelin
Hexarelin bụ peptide peptide na-eto eto na-eto eto sịntetik na GHSR-1a agonist dị ike, mepụtara iji kpalite ntọhapụ nke hormone uto endogenous (GH). Ọ bụ nke ezinụlọ ghrelin mimetic ma mejupụtara amino acid isii (hexapeptide), na-enye nkwụsi ike nke metabolic yana mmetụta mwepụta GH siri ike ma e jiri ya tụnyere analogs mbụ dị ka GHRP-6.
Njirimara API:
Ịdị ọcha ≥ 99%
Emepụtara site na njikọ peptide siri ike (SPPS)
Ụkpụrụ GMP dị ka, endotoxin dị ala na ihe fọdụrụ na ihe mgbaze
Ọbịbịa na-agbanwe agbanwe: R&D ruo nha azụmahịa
-
Melanotan II
Njirimara API:
Ịdị ọcha dị elu ≥ 99%
Ejikọtara ya site na njikọ peptide siri ike (SPPS)
Endotoxin dị ala, ihe mgbaze dị ala
Dị na R&D n'ọtụtụ azụmahịa -
Melanotan 1
Emepụtara Melanotan 1 API site na iji teknụzụ siri ike peptide synthesis (SPPS) n'okpuru ọnọdụ njikwa mma dị ka GMP siri ike.
-
Ịdị ọcha dị elu ≥99%
-
Ngwakọta peptide siri ike (SPPS)
-
Ụkpụrụ nrụpụta dị ka GMP
-
Akwụkwọ zuru ezu: COA, MSDS, data kwụsie ike
-
Nkwanye nwere ike ịgbakọ: R&D ruo ọkwa azụmahịa
-